Atomera Incorporated (NASDAQ:ATOM) Q1 2023 Earnings Conference Call April 26, 2023 5:00 PM ET Company Participants Mike Bishop – Investor Relations Scott Bibaud – President and Chief Executive Officer Frank Laurencio – Chief Financial Officer Conference Call Participants Richard Shannon – Craig-Hallum Cody Acree – Benchmark Mike Bishop Hello, everyone, and welcome to Atomera's First Quarter Fiscal Year 2023 Update Call. I'd like to remind everyone that this call and webinar are being recorded, and a replay ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2023. or ☐ Transition Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) | --- | --- | ...

Atomera Incorporated (NASDAQ:ATOM) Q4 2022 Earnings Conference Call February 15, 2023 5:00 PM ET Company Participants Mike Bishop - IR Scott Bibaud - President and CEO Frank Laurencio - CFO Conference Call Participants Cody Acree - Benchmark Richard Shannon - Craig-Hallum Mike Bishop Hello, everyone, and welcome to Atomera's Fourth Quarter Fiscal Year 2022 Update Call. I'd like to remind everyone that this call and webinar are being recorded, and a replay will be available on Atomera's IR website for one ye ...

Q4 2022 Conference Call February 15, 2023 Atomera Incorporated 1 Safe Harbor This presentation contains forward-looking statements concerning Atomera Incorporated (""Atomera," the "Company," "we," "us," and "our"). The words "believe," "may," "will," "potentially," "estimate," "continue," "anticipate," "intend," "could," "would," "project," "plan," "expect" and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward- looking statements. These forward-looking ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) Delaware 30-0509586 (State or Other jurisdiction ...

Financial Data and Key Metrics Changes - The GAAP net loss for Q3 2022 was $4.6 million or $0.20 per share, slightly up from a net loss of $4.5 million in Q2 2022, which was also $0.20 per share [19] - GAAP operating expenses in Q3 2022 were $4.7 million, an increase of approximately $210,000 over Q2 2022 [20] - The cash balance at September 30, 2022, was $23.3 million, compared to $21.8 million at the end of Q2 2022, reflecting an increase of $1.5 million [21] Business Line Data and Key Metrics Changes - The company continues to see strong interest in its two most mature MST solutions, MST-SP and MST for RF-SOI, with growing customer engagement [12] - Development activity by customers is increasing, leading to additional wafer runs and interest from new customers seeking competitive advantages [8] Market Data and Key Metrics Changes - The semiconductor industry is experiencing a softening of demand, leading to forecast reductions and some reductions in projected capital expenditures [7] - Despite the slowdown, there is still a plentiful allocation of CapEx budgets to support the acquisition of new technologies and equipment [8] Company Strategy and Development Direction - The company is focused on driving customers to adopt MST technology, particularly those who are further along in their development [8] - Atomera aims to leverage the current industry environment to increase licensing activity and move towards commercialization [18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the current industry cycle, believing it provides a favorable environment for Atomera to grow and adopt its technology [18] - The company is confident that the slowdown in the semiconductor industry will lead to increased interest in cost-reducing technologies like MST [44] Other Important Information - The company is not providing revenue guidance beyond the current quarter, consistent with past practices, and expects Q4 revenue to be zero [22] - The company has a diverse array of applications where customers need innovative breakthroughs, indicating a strong engagement pipeline [22] Q&A Session Summary Question: Expansion of JDA customer relationships - Management indicated that while they are not discussing expansion into different business units yet, they are working closely with existing customers and hope to reach license agreements soon [28] Question: Customer utilization and prioritization of R&D wafers - Management noted that customers are now able to plan new wafer runs without issues, indicating a positive shift in customer engagement [30] Question: Confidence in licensing gate-all-around technologies - Management expressed optimism about intersecting with future technology developments, believing their technology will be applicable even if not immediately adopted [34] Question: Exposure to the China market - Management stated that they currently have no significant exposure to China and are cautious due to IP concerns, but see potential opportunities if the trade situation improves [40] Question: Customer attitudes towards spending in 2023 - Management remains optimistic about customer spending, noting that while some have scaled back forecasts, they are still spending significantly more than in previous years [49] Question: Visibility on future revenue - Management acknowledged the frustration with zero revenue forecasts but indicated that several customers are close to obtaining manufacturing licenses, which would provide more visibility [52]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020. or ¨ Transition Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) Delaware ...

Table of Contents Delaware 30-0509586 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock: Par value $0.001 ATOM Nasdaq Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2020. or ¨ Transition R ...

Table of Contents Delaware 30-0509586 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock: Par value $0.001 ATOM Nasdaq Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2020. or ¨ Transition ...

Financial Performance - Revenue for the year ended December 31, 2019 was approximately $533,000, an increase from $246,000 in 2018, representing a growth of 116.3%[120] - Cost of revenue for 2019 was approximately $253,000, up from $148,000 in 2018, indicating a rise of 70.3%[121] - Operating expenses totaled approximately $13.9 million for 2019, compared to $13.2 million in 2018, reflecting an increase of 5.3%[122] - The net loss for the year ended December 31, 2019 was approximately $13.3 million, compared to a net loss of approximately $12.9 million in 2018[131] Expenses Breakdown - Research and development expenses for 2019 were approximately $7.7 million, an increase of 6% from $7.3 million in 2018[124] - General and administrative expenses rose to approximately $5.2 million in 2019, up 5% from $5.0 million in 2018[125] Cash Position - As of December 31, 2019, cash and cash equivalents were approximately $14.9 million, with working capital of approximately $13.5 million[131] - Net cash used in operating activities for 2019 was approximately $10.4 million, primarily due to the net loss adjusted for stock-based compensation[134] Future Outlook - The company anticipates increased fees from license agreements and royalties as it enters into manufacturing and distribution license agreements[118] - Future capital requirements will depend on the successful commercialization of technology and potential collaborations or acquisitions[133]